 Establishment Labs Holdings Inc. ESTA, a medical technology company focused on womens health, initially in the breast aesthetics and reconstruction market, today announced that the U.S. Patent Trademark Office has issued a patent protecting its proprietary implant surface technology. The 979 patent epitomizes the Companys dedication to improving patient safety and post-operative outcomes by advancing technology. This patent protects the fundamental characteristics of the unique surface technology found in our popular Motiva Implants, currently available to patients in over 80 countries and now being studied in our U.S. clinical trial, said Juan José Chacón-Quirós, Chief Executive Officer. 